Administration normal mice stimulates B-lymphopoiesis peripheral lymphadenopathy Normal mice various periods time days cellularity phenotypic composition thymus spleen lymph node bone marrow days treatment significant increases cellularity spleen lymph node bone marrow normal range days cessation treatment days treatment numbers IgM- bone marrow cells days treatment numbers significant population cells spleen numbers mu+/sIgM- cells mice Analysis expression sIgM- bone marrow cells population treatment size population control mice pre-B cell numbers cessation treatment days treatment twofold increase number cells spleen lymph node cell numbers normal values days cessation administration spleens mice significant increase number cells immature phenotype sIgMhi/sIgDlo decreased levels Ia FcR expression numbers cells lymph node spleen mice numbers normal levels cessation treatment 